Published in Int J Cancer on May 01, 2001
Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer (2010) 3.95
Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci U S A (2002) 3.81
Phosphorylation and stabilization of HURP by Aurora-A: implication of HURP as a transforming target of Aurora-A. Mol Cell Biol (2005) 1.54
Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc Natl Acad Sci U S A (2004) 1.50
The Schizosaccharomyces pombe aurora-related kinase Ark1 interacts with the inner centromere protein Pic1 and mediates chromosome segregation and cytokinesis. Mol Biol Cell (2002) 1.33
Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions. Cancer (2008) 1.32
Suppression of p160ROCK bypasses cell cycle arrest after Aurora-A/STK15 depletion. Proc Natl Acad Sci U S A (2004) 1.27
Gene expression profiles of microdissected pancreatic ductal adenocarcinoma. Virchows Arch (2003) 1.18
Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma. Head Neck (2009) 1.17
Perimembrane Aurora-A expression is a significant prognostic factor in correlation with proliferative activity in non-small-cell lung cancer (NSCLC). Ann Surg Oncol (2007) 1.15
The potential role of Aurora kinase inhibitors in haematological malignancies. Br J Haematol (2011) 1.08
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. Br J Cancer (2005) 1.07
Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. Clin Cancer Res (2007) 1.07
Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer. Int J Endocrinol (2014) 1.07
Constitutive phosphorylation of aurora-a on ser51 induces its stabilization and consequent overexpression in cancer. PLoS One (2007) 1.07
Conditional transgenic system for mouse aurora a kinase: degradation by the ubiquitin proteasome pathway controls the level of the transgenic protein. Mol Cell Biol (2005) 1.04
Retracted Identification of Aurora-A as a direct target of E2F3 during G2/M cell cycle progression. J Biol Chem (2008) 1.04
The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis. Front Oncol (2012) 1.01
Aurora-A identifies early recurrence and poor prognosis and promises a potential therapeutic target in triple negative breast cancer. PLoS One (2013) 1.01
Assessment of the in vivo antitumor effects of ENMD-2076, a novel multitargeted kinase inhibitor, against primary and cell line-derived human colorectal cancer xenograft models. Clin Cancer Res (2010) 0.98
Heterogeneity of mammary lesions represent molecular differences. BMC Cancer (2006) 0.98
Astrin regulates Aurora-A localization. Biochem Biophys Res Commun (2008) 0.97
Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients. BMC Cancer (2012) 0.97
Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase. J Biol Chem (2012) 0.97
Cdk1, Plks, Auroras, and Neks: the mitotic bodyguards. Adv Exp Med Biol (2008) 0.96
Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1. Mol Biol Cell (2008) 0.94
The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1. Nucleic Acids Res (2002) 0.94
Regulation of centrosomes by the BRCA1-dependent ubiquitin ligase. Cancer Biol Ther (2008) 0.93
Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray. Neoplasia (2004) 0.92
Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation. PLoS Pathog (2012) 0.91
Mitosis as an anti-cancer drug target. Chromosoma (2013) 0.88
Targeting the cell cycle in esophageal adenocarcinoma: an adjunct to anticancer treatment. World J Gastroenterol (2011) 0.87
Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen. J Cancer Res Clin Oncol (2010) 0.86
Aurora-A Kinase as a Promising Therapeutic Target in Cancer. Front Oncol (2016) 0.86
Aurora-A kinase interacting protein 1 (AURKAIP1) promotes Aurora-A degradation through an alternative ubiquitin-independent pathway. Biochem J (2007) 0.85
Association of loss of BRCA1 expression with centrosome aberration in human breast cancer. J Cancer Res Clin Oncol (2008) 0.84
Mutations in normal breast tissue and breast tumours. Breast Cancer Res (2001) 0.84
Control of centrin stability by Aurora A. PLoS One (2011) 0.84
Id1 overexpression induces tetraploidization and multiple abnormal mitotic phenotypes by modulating aurora A. Mol Biol Cell (2008) 0.84
A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer. BMC Cancer (2013) 0.84
Overexpression of Aurora-A in primary cells interferes with S-phase entry by diminishing Cyclin D1 dependent activities. Mol Cancer (2011) 0.83
Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT. BMC Cancer (2011) 0.83
A SUMOylation Motif in Aurora-A: Implications for Spindle Dynamics and Oncogenesis. Front Oncol (2011) 0.82
Finding the needle in the haystack: why high-throughput screening is good for your health. Breast Cancer Res (2002) 0.82
Bisphenol A directly targets tubulin to disrupt spindle organization in embryonic and somatic cells. ACS Chem Biol (2008) 0.82
Scientific Rationale Supporting the Clinical Development Strategy for the Investigational Aurora A Kinase Inhibitor Alisertib in Cancer. Front Oncol (2015) 0.81
AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128. Sci Rep (2016) 0.79
NCIC CTG IND.181: phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignancies. Invest New Drugs (2013) 0.78
Aurora-A kinase-inactive mutants disrupt the interaction with Ajuba and cause defects in mitotic spindle formation and G2/M phase arrest in HeLa cells. BMB Rep (2014) 0.78
Identification of Ski as a target for Aurora A kinase. Biochem Biophys Res Commun (2011) 0.77
Aurora-A is an efficient marker for predicting poor prognosis in human nasopharyngeal carcinoma with aggressive local invasion: 208 cases with a 10-year follow-up from a single institution. Oncol Lett (2012) 0.77
Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway. BMC Cancer (2009) 0.77
Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer. Carcinogenesis (2016) 0.77
Generation and characterization of novel monoclonal antibodies against human aurora-A. Hybridoma (Larchmt) (2008) 0.77
Association between the STK15 polymorphisms and risk of cancer: a meta-analysis. Mol Genet Genomics (2014) 0.76
The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism. Oncotarget (2014) 0.76
How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity. Cancer Metastasis Rev (2015) 0.76
Can the centrosome be a marker for DNA ploidy in breast cancer? J Cytol (2012) 0.75
FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells. Oncogene (2017) 0.75
Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity (2000) 10.34
Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. Science (1988) 3.99
Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science (2000) 2.67
Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. Neurology (2002) 2.66
Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet (1995) 2.53
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. Ann Oncol (2014) 2.50
Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res (1998) 2.42
Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med (1990) 2.39
Hox C cluster genes are dispensable for overall body plan of mouse embryonic development. Dev Biol (2000) 2.04
Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol (1999) 1.98
Gene induction pathways mediated by distinct IRFs during viral infection. Biochem Biophys Res Commun (2001) 1.97
The zinc fingers of human poly(ADP-ribose) polymerase are differentially required for the recognition of DNA breaks and nicks and the consequent enzyme activation. Other structures recognize intact DNA. J Biol Chem (1990) 1.97
Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells (1996) 1.86
Isolation and characterization of an Escherichia coli mutant lacking tRNA-guanine transglycosylase. Function and biosynthesis of queuosine in tRNA. J Biol Chem (1982) 1.77
Primary structure of the alpha-subunit of Torpedo californica (Na+ + K+)ATPase deduced from cDNA sequence. Nature (1985) 1.71
Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg (2001) 1.65
Balloon-occluded retrograde transvenous obliteration (BRTO), a promising nonsurgical therapy for ectopic varices: a case report of successful treatment of duodenal varices by BRTO. Am J Gastroenterol (1996) 1.65
Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg (2000) 1.60
Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells (1998) 1.59
Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology (2007) 1.53
High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease. Endocr J (2001) 1.53
Neuronal nitric-oxide synthase is regulated by the Hsp90-based chaperone system in vivo. J Biol Chem (1999) 1.51
Transareolar endoscopy-assisted partial mastectomy: a preliminary report of six cases. Surg Laparosc Endosc Percutan Tech (2001) 1.50
From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve (1998) 1.48
Novel mechanism of post-transcriptional modification of tRNA. Insertion of bases of Q precursors into tRNA by a specific tRNA transglycosylase reaction. J Biol Chem (1979) 1.46
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Apolipoprotein E genotype and Alzheimer's disease. Lancet (1993) 1.44
Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors. J Nucl Med (1996) 1.43
Regulation of IFN-alpha/beta genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-alpha/beta. Genes Cells (1996) 1.42
Nucleotide sequence of a full-length cDNA for human fibroblast poly(ADP-ribose) polymerase. Biochem Biophys Res Commun (1987) 1.42
Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology (2001) 1.41
Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study. Liver Transpl (2001) 1.40
Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy. Hum Mol Genet (1996) 1.39
Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer (1970) 1.34
Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. Eur J Biochem (1994) 1.33
Structure determination of a nucleoside Q precursor isolated from E. coli tRNA: 7-(aminomethyl)-7-deazaguanosine. Nucleic Acids Res (1978) 1.32
Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. Hum Mol Genet (1999) 1.32
Common pathological mechanisms in mouse models for muscular dystrophies. FASEB J (2005) 1.31
Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res (1998) 1.31
Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer (1999) 1.29
Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet (1995) 1.28
Targeted disruption of CRE-binding factor TREB5 gene leads to cellular necrosis in cardiac myocytes at the embryonic stage. Biochem Biophys Res Commun (1999) 1.28
Quantitative analysis of estrogen receptor-beta mRNA and its variants in human breast cancers. Int J Cancer (2000) 1.27
Stimulation of the Na+/K+ pump by external [K+] is regulated by voltage-dependent gating. J Biol Chem (1991) 1.27
Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Hum Mol Genet (2000) 1.23
POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in alpha-DG. Neurology (2004) 1.22
Three-dimensional structure of Escherichia coli glutathione S-transferase complexed with glutathione sulfonate: catalytic roles of Cys10 and His106. J Mol Biol (1998) 1.22
Characterization of a rat tRNA gene cluster containing the genes for tRNAAsp, tRNAGly and tRNAGlu, and pseudogenes. Nucleic Acids Res (1982) 1.22
Structural differences between a ras oncogene protein and the normal protein. Nature (1989) 1.20
Restriction map of double-stranded DNA copy synthesized from poliovirus Sabin 1 RNA. J Biochem (1982) 1.18
Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin Cancer Res (1999) 1.16
Synthesis and expression of a synthetic gene for the activated human c-Ha-ras protein. Jpn J Cancer Res (1986) 1.16
Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer (1997) 1.15
Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest (1995) 1.15
Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer. Eur J Surg Oncol (2010) 1.15
Fukutin-related protein gene mutated in the original kindred limb-girdle MD 2I. Neurology (2003) 1.15
Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Hum Mol Genet (1996) 1.14
Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas. Int J Cancer (2000) 1.13
Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol (2001) 1.12
Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas. Cancer (1986) 1.11
Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J Immunol (1998) 1.11
Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid (1998) 1.11
c-myc expression is associated with increased proliferation activity in thyroid follicular cells of Graves' disease as stimulated by autoantibodies. Eur J Endocrinol (1996) 1.10
Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer. Ann Oncol (2007) 1.10
Cytochrome c oxidase contains an extra charged amino acid cluster in a new type of respiratory chain in the amino-acid-producing Gram-positive bacterium Corynebacterium glutamicum. Microbiology (2001) 1.09
Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology (2004) 1.09
Characterization of the Asian myopathy patients with VCP mutations. Eur J Neurol (2011) 1.08
Spontaneous rupture of adrenal pheochromocytoma: a case report. J Urol (1994) 1.07
Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US. Eur J Nucl Med (2001) 1.05
Occurrence of 1-methyladenosine and absence of ribothymidine in transfer ribonucleic acid of Mycobacterium smegmatis. J Bacteriol (1979) 1.05
Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas. Gynecol Obstet Invest (1999) 1.05
Isolation of Q nucleoside precursor present in tRNA of an E. coli mutant and its characterization as 7-(cyano)-7-deazaguanosine. Nucleic Acids Res (1978) 1.05
Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells. J Pathol (2006) 1.05
Topical gentian violet for cutaneous infection and nasal carriage with MRSA. Int J Dermatol (2000) 1.04
Primary collagen VI deficiency is the second most common congenital muscular dystrophy in Japan. Neurology (2007) 1.04
Molecular pathomechanism of distal myopathy with rimmed vacuoles. Acta Myol (2005) 1.03
A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy. Maturitas (1999) 1.03
Voltage-dependent inhibition of the sodium pump by external sodium: species differences and possible role of the N-terminus of the alpha-subunit. Eur Biophys J (1993) 1.03
Carcinoembryonic antigens in the pericardial fluid of patients with malignant pericarditis. Oncology (1984) 1.03
Breast cancer risk associated with polymorphism in CYP19 in Japanese women. Int J Cancer (2000) 1.02
A novel hydrophobic diheme c-type cytochrome. Purification from Corynebacterium glutamicum and analysis of the QcrCBA operon encoding three subunit proteins of a putative cytochrome reductase complex. Biochim Biophys Acta (2001) 1.01
Primary structure of the beta-subunit of Torpedo californica (Na+ + K+)-ATPase deduced from the cDNA sequence. FEBS Lett (1986) 1.01
Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss. Hum Reprod (2002) 1.01
The loss of retinoblastoma gene in association with c-myc and transforming growth factor-beta 1 gene expression in human bladder cancer. J Urol (1995) 1.00
Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction. Cancer (2000) 1.00
Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. Nucl Med Commun (2003) 1.00
Dystrophin-associated protein A0 is a homologue of the Torpedo 87K protein. FEBS Lett (1995) 0.99
Novel FHL1 mutations in fatal and benign reducing body myopathy. Neurology (2009) 0.99
Cervical thymoma and incidence of cervical thymus. Acta Pathol Jpn (1983) 0.99
The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression. Hum Mol Genet (2001) 0.98
Site-directed mutagenesis of Asp-376, the catalytic phosphorylation site, and Lys-507, the putative ATP-binding site, of the alpha-subunit of Torpedo californica Na+/K(+)-ATPase. Biochim Biophys Acta (1990) 0.98
Comparison of the incidence of association of periodic paralysis and hyperthyroidism in Japan in 1957 and 1991. Endocrinol Jpn (1992) 0.98
A sarcoglycan-dystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system. Hum Mol Genet (2000) 0.98
Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res (2000) 0.98
Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients. Oncol Rep (2000) 0.97
Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter. J Urol (1999) 0.97